3 Firms Shape $384M Cancer Biopharma Co. Take-Private Deal
Biopharmaceutical cancer research business Cellular Biomedicine Group said Wednesday it's agreed to be taken private by a group that includes current investors and members of its senior management team in a...To view the full article, register now.
Already a subscriber? Click here to view full article